From Research Setbacks to Treatment Opportunities in ALS
RADICAVA (edaravone) has undeniably reshaped how clinicians approach ALS, introducing a disease-modifying dimension that transcends conventional symptomatic interventions. With the debut of RADICAVA ORS oral suspension, patients now enjoy unprecedented convenience, sidestepping the logistical challenges tied to regular intravenous sessions. Real-world data supports tangible benefits in...
0 Comments 0 Shares 46 Views 0 Reviews